Evogen Licenses LGC's PCR Probe Technology | GenomeWeb

NEW YORK (GenomeWeb News) — Molecular diagnostics developer Evogen said this week that it has licensed PCR probe technology from LGC.

Under the agreement, Evogen has signed a worldwide license for LGC's HyBeacons technology to augment its molecular diagnostics and detection technology, including the EvoCycler platform.

The exclusive license also gives Evogen the right to sub-license the technology within its market areas, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.